Literature DB >> 16944114

The influence of levodopa-induced dyskinesias on manual tracking in patients with Parkinson's disease.

Sarah Lemieux1, Mehrdad Ghassemi, Mandar Jog, Roderick Edwards, Christian Duval.   

Abstract

The influence of peak-dose, levodopa-induced dyskinesias (LID) on manual tracking (MT) was examined in 10 dyskinetic patients with Parkinson's disease (DPD), and compared to 10 age/gender-matched non-dyskinetic patients with Parkinson's disease (NDPD) and 10 healthy controls. Whole-body movement (WBM) and MT performance were recorded simultaneously with a 6-degrees-of-freedom magnetic motion tracker and forearm rotation sensors, respectively. Subjects were asked to match the length of a computer-generated line with a line they controlled via wrist rotation. Results show that DPD patients had greater WBM magnitude at rest and during the motor task, both in displacement and in velocity. All groups displayed some increase in WBM displacement from rest to MT, but only the DPD group had a significant increase in WBM velocity during movement. As for MT performance (determined by assessing the positional mismatch between subjects' and target lines), ERROR in displacement was statistically similar between groups. There was no correlation between ERROR and the magnitude of WBM within the DPD group. The DPD group showed significant increased ERROR when the velocity of the subject's line was compared with that of the velocity of the target line. When two distinct target pace segments were examined (FAST/SLOW), no significant differences were found in ERROR for displacement for either group, but both the NDPD and DPD group showed increased ERROR from SLOW to FAST for velocity. This was accompanied with an increase in WBM velocity only in the DPD group. The lack of increased ERROR during the SLOW tracking portion in the DPD group supports the notion that the dyskinesias themselves were not primarily responsible for the ERROR seen in the patients. When examining the positive or negative values of ERROR (i.e., faster or slower than the target), we found that the increased ERROR in velocity observed in the DPD group was the result of excess velocity rather than bradykinesia, manifested as isolated deviations from the target trace in the DPD group that were coherent in time with increased ERROR in velocity. In conclusion, evidence presented in the present study shows that the LID was not the primary cause of the ERROR seen in the DPD group. Accordingly, we propose that the increased ERROR seen in the DPD group resulted from a mechanism distinct from the one generating LID.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16944114     DOI: 10.1007/s00221-006-0632-2

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  34 in total

1.  The impact of ventrolateral thalamotomy on tremor and voluntary motor behavior in patients with Parkinson's disease.

Authors:  Christian Duval; Michel Panisset; Antonio P Strafella; Abbas F Sadikot
Journal:  Exp Brain Res       Date:  2005-11-23       Impact factor: 1.972

2.  Force overflow and levodopa-induced dyskinesias in Parkinson's disease.

Authors:  Roland Wenzelburger; Bao-Rong Zhang; Sabine Pohle; Stephan Klebe; Delia Lorenz; Jan Herzog; Henrik Wilms; Günther Deuschl; Paul Krack
Journal:  Brain       Date:  2002-04       Impact factor: 13.501

3.  Treatment of parkinsonism with levodopa.

Authors:  M D Yahr; R C Duvoisin; M J Schear; R E Barrett; M M Hoehn
Journal:  Arch Neurol       Date:  1969-10

4.  Worsening of levodopa-induced dyskinesias by motor and mental tasks.

Authors:  F Durif; M Vidailhet; B Debilly; Y Agid
Journal:  Mov Disord       Date:  1999-03       Impact factor: 10.338

5.  Effects of levodopa and viscosity on the velocity and accuracy of visually guided tracking in Parkinson's disease.

Authors:  M T Johnson; A N Kipnis; J D Coltz; A Gupta; P Silverstein; F Zwiebel; T J Ebner
Journal:  Brain       Date:  1996-06       Impact factor: 13.501

6.  Clinical-pathological study of levodopa complications.

Authors:  Azi H Rajput; Mark E Fenton; Sam Birdi; Rob Macaulay; David George; Bohdar Rozdilsky; Lee C Ang; Ambikaipakan Senthilselvan; Oleh Hornykiewicz
Journal:  Mov Disord       Date:  2002-03       Impact factor: 10.338

7.  Two-dimensional tracing and tracking in patients with Parkinson's disease.

Authors:  S Hocherman; J Aharon-Peretz
Journal:  Neurology       Date:  1994-01       Impact factor: 9.910

8.  Fast complex arm movements in Parkinson's disease.

Authors:  A Berardelli; N Accornero; M Argenta; G Meco; M Manfredi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-10       Impact factor: 10.154

9.  Human ballistic arm abduction movements: effects of L-dopa treatment in Parkinson's disease.

Authors:  A Baroni; F Benvenuti; L Fantini; T Pantaleo; F Urbani
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

10.  Visual "closed-loop" and "open-loop" characteristics of voluntary movement in patients with Parkinsonism and intention tremor.

Authors:  K A Flowers
Journal:  Brain       Date:  1976-06       Impact factor: 13.501

View more
  4 in total

1.  Comparing movement patterns associated with Huntington's chorea and Parkinson's dyskinesia.

Authors:  Rena K Mann; Roderick Edwards; Julie Zhou; Alison Fenney; Mandar Jog; Christian Duval
Journal:  Exp Brain Res       Date:  2012-03-21       Impact factor: 1.972

2.  L-dopa induces under-damped visually guided motor responses in Parkinson's disease.

Authors:  Wing-Lok Au; Ni Lei; Meeko M K Oishi; Martin J McKeown
Journal:  Exp Brain Res       Date:  2010-02-09       Impact factor: 1.972

3.  Cardinal Motor Features of Parkinson's Disease Coexist with Peak-Dose Choreic-Type Drug-Induced Dyskinesia.

Authors:  Etienne Goubault; Hung P Nguyen; Sarah Bogard; Pierre J Blanchet; Erwan Bézard; Claude Vincent; Mélanie Langlois; Christian Duval
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

Review 4.  Drug-induced dyskinesia in Parkinson's disease. Should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia?

Authors:  Jean-François Daneault; Benoit Carignan; Abbas F Sadikot; Michel Panisset; Christian Duval
Journal:  BMC Med       Date:  2013-03-20       Impact factor: 8.775

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.